Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.62 +0.26%   SPY: 134.96 -0.17%
Quote Spy AGEN NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Agenus Inc (AGEN)

@ 11:03 AM
Click the portfolio to add AGEN:
Close [X]
+ Add AGEN to Portfolio
  
  Last Trade: $3.65 +0.18 (5.19%)
  Volume: 182,162 298% of avg daily volume
       
  Avg Volume: 113,015
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 3.54 - 3.72
  Open: 3.60
  Previous Close: 3.47
  52-wk Range: 1.92 - 6.72
  Market Cap: 62.5M
  P/E: -3.3
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (-0.5%)
Spy AGEN

? Pro holders
? Member holders
? Items submitted
Additional AGEN resources



Customize Links
To see which Pros and tickerspy members own AGEN Sign up now
Latest AGEN Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Agenus to Present at BIO CEO & Investor Conference
AGEN  
Linked by GlobeNewswire - February 06, 07:00AM from (www.globenewswire.com)
LEXINGTON, Mass., Feb. 6, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus to Present at OneMedForum San Francisco 2012
AGEN  
Linked by GlobeNewswire - January 04, 07:00AM from (www.globenewswire.com)
LEXINGTON, Mass., Jan. 4, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus and ChemRar Enter Into Agreement in the Area of Personalized Cancer Vaccines
AGEN  
Linked by GlobeNewswire - December 19, 07:00AM from (www.globenewswire.com)
LEXINGTON, Mass. and MOSCOW, Dec. 19, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a biotechnology company working  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus Vaccine for Brain Cancer Highlighted at Current State of the Art Session at the Annual Society for Neuro-Oncology (SNO) Meeting
AGEN  
Linked by GlobeNewswire - November 16, 07:00AM from (www.globenewswire.com)
LEXINGTON, Mass., Nov. 16, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) reported today that Dr. Michael Sughrue, incoming  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus Reports Third Quarter 2011 Financial Results and Corporate Updates
AGEN  
Linked by GlobeNewswire - October 27, 07:00AM from (www.globenewswire.com)
LEXINGTON, Mass., Oct. 27, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) reported today its results for the third quarter  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus to Report Third Quarter Financial Results on October 27, 2011; Conference Call to Follow
AGEN  
Linked by GlobeNewswire - October 20, 07:00AM from (www.globenewswire.com)
LEXINGTON, Mass., Oct. 20, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) will release its third quarter financial results  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Positive Results Shown With Agenus' QS-21 Stimulon(R) Adjuvant in Phase 3 Trial of GlaxoSmithKline's Malaria Vaccine
AGEN  GSK  
Linked by GlobeNewswire - October 18, 01:00PM from (www.globenewswire.com)

LEXINGTON, Mass., Oct. 18, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus to Present at NewsMakers in the Biotech Industry Conference
AGEN  
Linked by GlobeNewswire - October 18, 07:00AM from (www.globenewswire.com)
LEXINGTON, Mass., Oct. 18, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus Compliant With NASDAQ Listing Requirements
AGEN  
Linked by GlobeNewswire - October 17, 01:10PM from (www.globenewswire.com)
LEXINGTON, Mass., Oct. 17, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) today announced that it has received notice  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Agenus Announces Stock Symbol to Revert Back to AGEN
AGEN  
Linked by GlobeNewswire - October 11, 11:10AM from (www.globenewswire.com)
LEXINGTON, Mass., Oct. 11, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEND), a developer of therapeutic vaccines for cancer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource